Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Pregabalin NDC 71335-2343 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - lbl713352343

Label - lbl713352343

Each capsule contains 100 mg of Pregabalin. These capsules are used for medication. The National Drug Code (NDC) for this product is 71335-2343-1. It is important to keep this medication and all drugs out of reach from children. The capsules should be stored at a temperature of 25°C (77°F), with excursions permitted to 15° to 30°C (59° to 86°F) as specified by the USP Controlled Room Temperature guidelines. The medication should be dispensed in a tight, child-resistant container. Each package contains 30 capsules. The medication has been repackaged by Bryant Ranch Prepack, Inc. and manufactured by StieGen Pharmaceuticals, Inc. For more information, refer to the Medication Guide provided by the manufacturer.*

Figure 1 - pregabalin fig01

Figure 1 - pregabalin fig01

Figure 2 - pregabalin fig02

Figure 2 - pregabalin fig02

Figure 3 - pregabalin fig03

Figure 3 - pregabalin fig03

Figure 4 - pregabalin fig04

Figure 4 - pregabalin fig04

Figure 5 - pregabalin fig05

Figure 5 - pregabalin fig05

Figure 6 - pregabalin fig06

Figure 6 - pregabalin fig06

Figure 7 - pregabalin fig07

Figure 7 - pregabalin fig07

Figure 9 - pregabalin fig08

Figure 9 - pregabalin fig08

Figure 10 - pregabalin fig09

Figure 10 - pregabalin fig09

Figure 11 - pregabalin fig10

Figure 11 - pregabalin fig10

The text appears to be a data table showing the percentage of subjects who improved from baseline to week 12 in two different treatments (Pregetalin and Placeso). However, the text is not entirely clear and some characters are not readable. Therefore, a complete and accurate description cannot be generated.*

Figure 12 - pregabalin fig11

Figure 12 - pregabalin fig11

This text provides information about the percent of subjects who improved from baseline to week 16 in a study comparing the effects of Pregabalin and Placebo. The percent improvement is shown for different values ranging from 100 to 280.*

Figure 13 - pregabalin fig13

Figure 13 - pregabalin fig13

This text appears to be a table showing responder rates for different treatments. The first column shows the "Responder Rate (%)" values, and the subsequent columns show different percentages. There is a column labeled "Placebo" with the values "2.5 mglkglday" and "10 mg/kglday". The last row appears to show some numerical values, possibly related to the responder rates. The information provided is limited, but it seems to be related to a medical or clinical study.*

Cockcroft and Gault equation - pregabalin formula

Cockcroft and Gault equation - pregabalin formula

This is a formula that calculates CLCT (Creatinine Clearance) based on age, weight, and serum creatinine levels. The calculation involves subtracting the age in years (in this case, indicated as 140) from weight in kilograms, and then multiplying it by a factor of 0.85 for female patients. The result is then multiplied by 72 and the serum creatinine level in mg/dL.*

Chemical Structure - pregabalin str

Chemical Structure - pregabalin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.